Primary biliary cirrhosis (PBC) with initial normal bilirubin concentration: Treatment with ursodeoxycholic acid (UDCA) does not affect liver-related survival

被引：0
|
作者：
Rigamonti, Cristina
Floreani, Annaroso
Variola, Angela
Casazza, Giovanni
Burroughs, Andrew K.
Patch, David
机构：
[1] IRCCS Fdn Osped Maggiore Policlin, Div Gastroenterol 1, Milan, Italy
[2] Univ Padua, Dept Surg & Gastroenterol Sci, I-35100 Padua, Italy
[3] Univ Milan, Dept Stat & Biometry, I-20122 Milan, Italy
[4] Royal Free Hosp, Liver Transplantat & Hepatobiliary Med, London NW3 2QG, England
来源：
HEPATOLOGY | 2007年 / 46卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
698
引用
收藏
页码：547A / 548A
页数：2
相关论文
共 50 条
  • [41] BENEFICIAL EFFECT OF URSODEOXYCHOLIC ACID (UDCA) IN PRIMARY BILIARY-CIRRHOSIS (PBC) - FINAL RESULTS OF THE FRENCH-CANADIAN TRIAL
    POUPON, RE
    BALKAU, B
    POUPON, R
    HEPATOLOGY, 1990, 12 (04) : 872 - 872
  • [42] LONG TERM TREATMENT OF PRIMARY BILIARY CHOLANGITIS (PBC) WITH URSODEOXYCHOLIC ACID (UDCA) - IDENTIFYING PREDICTORS OF RESPONSE.
    Haddadin, Yazan
    Hashim, Ahmed
    Vickers, Laura
    Jamil, Khaleel M.
    GASTROENTEROLOGY, 2019, 156 (06) : S348 - S348
  • [43] The combination of ursodeoxycholic acid (UDCA) and colchicine (C) for patients with primary biliary cirrhosis (PBC): Effect on hepatic function and portal hypertension
    Huet, PM
    Huet, J
    Poupon, RE
    Deslauriers, J
    HEPATOLOGY, 1996, 23 (01) : P132 - P132
  • [44] THE COMBINATION OF URSODEOXYCHOLIC ACID (UDCA) AND METHOTREXATE (MTX) FOR PATIENTS WITH PRIMARY BILIARY-CIRRHOSIS (PBC) - THE RESULTS OF A PILOT-STUDY
    LINDOR, KD
    JORGENSEN, RA
    ANDERSON, ML
    GORES, GJ
    BALDUS, WP
    DICKSON, ER
    HEPATOLOGY, 1994, 20 (04) : A202 - A202
  • [45] SINGLE-DOSE OR MULTIPLE DOSES OF URSODEOXYCHOLIC ACID (UDCA) ARE EQUALLY EFFECTIVE IN THE TREATMENT OF PRIMARY SCLEROSING CHOLANGITIS (PSC) AND PRIMARY BILIARY-CIRRHOSIS (PBC)
    VANDEMEEBERG, PC
    WOLFHAGEN, FHJ
    VANERPECUM, KJ
    SALEMANS, JMJI
    SCHALM, SW
    VANBERGEHENEGOUWEN, GP
    GASTROENTEROLOGY, 1995, 108 (04) : A1191 - A1191
  • [46] A Trial-based Model of Liver Transplant and Liver-related Death in Patients with Primary Biliary Cirrhosis (PBC)
    Carbone, Marco
    Pencek, Richard
    Mayne, Tracy J.
    Marmon, Tonya
    Mells, George F.
    Shapiro, David
    HEPATOLOGY, 2015, 62 : 287A - 288A
  • [47] The impact of ursodeoxycholic acid (UDCA) therapy with or without liver transplantation (OLT) on long-term survival in primary biliary cirrhosis.
    Corpechot, C
    Carrat, F
    Bahr, A
    Poupon, RE
    Poupon, R
    HEPATOLOGY, 2003, 38 (04) : 519A - 519A
  • [48] COMBINED TREATMENT WITH URSODEOXYCHOLIC ACID (UDCA) AND SECRETIN (SCT) AMELIORATES LIVER INJURY IN A MOUSE MODEL OF LATE STAGE PRIMARY BILIARY CHOLANGITIS (PBC).
    Kennedy, Lindsey
    Francis, Heather L.
    Ceci, Ludovica D.
    Marzioni, Marco
    Invernizzi, Pietro
    Meadows, Vik
    Mancinelli, Romina A.
    Onori, Paolo
    Franchitto, Antonio
    Gaudio, Eugenio
    Venter, Julie
    Meng, Fanyin
    Wu, Nan
    Alvaro, Domenico
    Gershwin, M. Eric
    Liangpunsakul, Suthat
    Alpini, Gianfranco
    Glaser, Shannon S.
    HEPATOLOGY, 2019, 70 : 774A - 774A
  • [49] NO EVIDENCE FOR A MORE ATHEROGENIC SERUM-LIPID PROFILE WITH URSODEOXYCHOLIC ACID (UDCA) THERAPY IN PATIENTS WITH PRIMARY BILIARY-CIRRHOSIS (PBC)
    MICHIELETTI, P
    WITTSULLIVAN, H
    STEINER, G
    CAUCH, K
    WALKER, V
    HEATHCOTE, EJL
    HEPATOLOGY, 1993, 18 (04) : A217 - A217
  • [50] Does antimitochondrial antibody status affect response to treatment in patients with primary biliary cirrhosis? Outcomes of ursodeoxycholic acid therapy and liver transplantation
    Kim, WR
    Poterucha, JJ
    Jorgensen, RA
    Batts, KP
    Homburger, HA
    Dickson, ER
    Krom, RAF
    Wiesner, RH
    Lindor, KD
    HEPATOLOGY, 1997, 26 (01) : 22 - 26
12345